Berger Mark Stanley 4
4 · Actinium Pharmaceuticals, Inc. · Filed Jul 16, 2019
Insider Transaction Report
Form 4
Berger Mark Stanley
Chief Medical Officer
Transactions
- Award
Options to purchase common stock
2019-07-12$0.23/sh+400,000$92,800→ 400,000 totalExercise: $0.23From: 2019-07-12Exp: 2029-07-12→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant.